Gesher Acquisition Corp. II

GSHRW

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

# Signal Note: Driehaus Capital Entry into Gesher Acquisition II Driehaus Capital's $3.3M position in Gesher Acquisition Corp.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 517,973Value: $3.3M

# Signal Note: Driehaus Capital Entry into Gesher Acquisition II Driehaus Capital's $3.3M position in Gesher Acquisition Corp. II (GSHRW) signals conviction in an undisclosed biotech target; Gesher is a blank-check vehicle with no announced merger partner as of this filing date. The timing and size of this growth-stage entry suggests the fund expects either near-term SPAC merger announcement or meaningful clinical/regulatory catalysts within the acquisition target's pipeline.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: